List of works - Folefac Aminkeng

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

scientific article

Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.

scientific article published on 16 October 2017

Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study

scientific article published on 23 April 2015

Association between the rs12255372 variant of the TCF7L2 gene and obesity in a Cameroonian population

scientific article published on 25 November 2015

Association of IL-2RA/CD25 with type 1 diabetes in the Belgian population.

scientific article published on 16 September 2010

Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients

scientific article published on 20 November 2013

Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon

scientific article published on 14 April 2015

DLL4 loss-of-function heterozygous mutations cause Adams-Oliver syndrome

scientific article published on 16 October 2015

EIF2AK4 genetic mutations cause a recessive form of rare and deadly lung disease, pulmonary veno-occlusive disease.

scientific article

GFI1B mutation causes autosomal dominant gray platelet syndrome

scientific article published on 09 April 2014

HINT1 mutations define a novel disease entity - autosomal recessive axonal neuropathy with neuromyotonia.

scientific article published on 29 October 2012

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent

scientific article

IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype-phenotype correlation in the Belgian population

scientific article published on 16 June 2009

KCNT1 mutations in ADNFLE and MMPSI: a new driver in the etiology and pathophysiology of early-onset epileptic syndromes.

scientific article

MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ

scientific article published on 01 January 2006

Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetes

scientific article published on 01 August 2006

PDGFRB mutation causes autosomal-dominant Penttinen syndrome.

scientific article published on 27 October 2015

Pharmacogenomic diversity in Singaporean populations and Europeans

scientific article

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

scientific article published on 16 May 2016

TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.

scientific article published on 11 June 2007

The emerging era of pharmacogenomics: current successes, future potential, and challenges

scientific article published on 09 May 2014

Using pharmacogenetics in real time to guide therapy: the warfarin example

scientific article published on 09 April 2014

WDR45 mutations define a novel disease entity--static encephalopathy of childhood with neurodegeneration in adulthood.

scientific article

List of works by Folefac Aminkeng

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.

Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study

Association between the rs12255372 variant of the TCF7L2 gene and obesity in a Cameroonian population

Association of IL-2RA/CD25 with type 1 diabetes in the Belgian population.

Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients

Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon

DLL4 loss-of-function heterozygous mutations cause Adams-Oliver syndrome

EIF2AK4 genetic mutations cause a recessive form of rare and deadly lung disease, pulmonary veno-occlusive disease.

GFI1B mutation causes autosomal dominant gray platelet syndrome

HINT1 mutations define a novel disease entity - autosomal recessive axonal neuropathy with neuromyotonia.

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent

IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype-phenotype correlation in the Belgian population

KCNT1 mutations in ADNFLE and MMPSI: a new driver in the etiology and pathophysiology of early-onset epileptic syndromes.

MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ

Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetes

PDGFRB mutation causes autosomal-dominant Penttinen syndrome.

Pharmacogenomic diversity in Singaporean populations and Europeans

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.

The emerging era of pharmacogenomics: current successes, future potential, and challenges

Using pharmacogenetics in real time to guide therapy: the warfarin example

WDR45 mutations define a novel disease entity--static encephalopathy of childhood with neurodegeneration in adulthood.